EP1978362 - Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.07.2011 Database last updated on 31.08.2024 | Most recent event Tooltip | 01.07.2011 | Application deemed to be withdrawn | published on 03.08.2011 [2011/31] | Applicant(s) | For all designated states Crossbeta Biosciences B.V. Padualaan 8 3584 CH Utrecht / NL | [2010/46] |
Former [2008/41] | For all designated states Crossbeta Biosciences B.V. Heidelberglaan 100 3584 CX Utrecht / NL | Inventor(s) | 01 /
Gebbink, Martijn Frans Ben Gerard Zaadkorrel 34 3755 HL Eemnes / NL | 02 /
Bouma, Barend Tappersgilde 3 3994 CE Houten / NL | 03 /
Kranenburg, Onno Wouter Pretoriusstraat 91 III 1092 GD Amsterdam / NL | 04 /
Kroon, Louise Maria Johanna Dominee van der Kraanplantsoen 22 3981 GN Bunnik / NL | [2008/41] | Representative(s) | Hatzmann, Martin V.O. Johan de Wittlaan 7 2517 JR Den Haag / NL | [N/P] |
Former [2008/41] | Hatzmann, Martin Vereenigde Johan de Wittlaan 7 2517 JR Den Haag / NL | Application number, filing date | 08153132.9 | 08.07.2003 | [2008/41] | Priority number, date | EP20020077797 | 09.07.2002 Original published format: EP 02077797 | [2008/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1978362 | Date: | 08.10.2008 | Language: | EN | [2008/41] | Type: | A3 Search report | No.: | EP1978362 | Date: | 11.02.2009 | [2009/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.01.2009 | Classification | IPC: | A61K31/00, A61K31/7004, A61K31/195, A61K31/197, A61K31/198, A61K39/395, A61K38/49, G01N33/53, C12N9/72, A61P9/10, A61P3/10, A61P7/04, A61P35/00, A61P31/00, A61P37/00, A61P25/28, A61P25/16, A61M1/36, A61P7/02, A61P29/00, A61P25/08, G01N33/68 | [2008/46] | CPC: |
A61K31/7004 (EP,US);
A61K31/00 (EP,US);
A61K31/195 (EP,US);
A61K31/197 (EP,US);
A61K31/198 (EP,US);
A61K38/49 (EP,US);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07K16/18 (EP,US);
C12N9/6459 (EP,US);
C12Y304/21069 (EP,US);
G01N33/6854 (EP,US);
G01N33/6896 (EP,US);
C07K2319/23 (EP,US);
G01N2333/9726 (EP,US);
G01N2800/042 (EP,US);
G01N2800/2821 (EP,US)
(-)
|
Former IPC [2008/41] | G01N33/53, C12N9/72, A61K31/197, A61K31/198, A61K31/7004, A61P9/10, A61P3/10, A61P7/04, A61P35/00, A61P31/00, A61P37/00, A61P25/28, A61P25/16, A61P7/02, A61P29/00, A61P25/08 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2008/41] | Title | German: | Cross-Beta-Struktur mit Amyloid-bindenden Proteinen und Verfahren für den Nachweis einer Cross-Beta-Struktur, zur Modulation der Fibrillenbildung von Cross-Beta-Strukturen und Cross-Beta-Struktur-vermittelter Toxizität | [2008/41] | English: | Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity | [2008/41] | French: | Structure bêta croisée comportant des protéines à liaison d'amyloïde et procédés de détection de la structure bêta croisée, pour moduler des structures bêta croisées à formation fibrille et pour moduler la toxicité en mesurant la structure bêta croisée | [2008/41] | Examination procedure | 20.03.2008 | Examination requested [2008/41] | 10.08.2009 | Amendment by applicant (claims and/or description) | 01.10.2009 | Despatch of a communication from the examining division (Time limit: M06) | 08.04.2010 | Reply to a communication from the examining division | 28.07.2010 | Despatch of a communication from the examining division (Time limit: M06) | 08.02.2011 | Application deemed to be withdrawn, date of legal effect [2011/31] | 16.03.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/31] | Parent application(s) Tooltip | EP03762927.6 / EP1536778 | Divisional application(s) | EP10185187.1 / EP2322154 | EP11153594.4 / EP2341348 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030762927) is 23.01.2006 | Fees paid | Renewal fee | 20.03.2008 | Renewal fee patent year 03 | 20.03.2008 | Renewal fee patent year 04 | 20.03.2008 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 15.07.2009 | Renewal fee patent year 07 | 15.07.2010 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO9639834 (UNIV NEW YORK [US]) [A] * the whole document *; | [A]US5750349 (SUZUKI NOBUHIRO [JP], et al) [A] * the whole document *; | [A]US6037458 (HIRAI FUMIYASU [JP], et al) [A] * the whole document *; | [A]US6136548 (ANDERSON STEPHEN [US]) [A] * the whole document *; | [A]WO0112598 (UNIV COLUMBIA [US], et al) [A] * the whole document *; | [X] - CHAUHAN A ET AL, "Media from rhabdomyosarcoma and neuroblastoma cell cultures stimulate in vitro aggregation and fibrillization of amyloid beta-protein.", NEUROCHEMICAL RESEARCH FEB 1997, (199702), vol. 22, no. 2, ISSN 0364-3190, pages 227 - 232, XP002498010 [X] 1-5,53,54 * abstract * * page 228, paragraph "Thioflavin T Fluorescence Spectroscopy" * DOI: http://dx.doi.org/10.1023/A:1027379926976 | [X] - ELGHETANY M T ET AL, "METHODS FOR STAINING AMYLOID IN TISSUES A REVIEW", STAIN TECHNOLOGY, WILLIAMS AND WILKINS, BALTIMORE, US, (19880101), vol. 63, no. 4, ISSN 0038-9153, pages 201 - 212, XP008051786 [X] 7 * abstract * * page 201, line 1 - page 202, line 16 * | [X] - KLUNK W E ET AL, "DEVELOPMENT OF SMALL MOLECULE PROBES FOR THE BETA-AMYLOID PROTEIN OF ALZHEIMER'S DISEASE", NEUROBIOLOGY OF AGING, TARRYTOWN, NY, US, (19940101), vol. 15, no. 6, ISSN 0197-4580, pages 691 - 698, XP000602786 [X] 7,8,53,54 * abstract * * paragraphs "Binding Assay to Synthetic Abeta(10-43)" and "Discussion" * * figure 7 * DOI: http://dx.doi.org/10.1016/0197-4580(94)90050-7 | [DX] - O'NUALLAIN BRIAN ET AL, "Conformational Abs recognizing a generic amyloid fibril epitope", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, (20020205), vol. 99, no. 3, ISSN 0027-8424, pages 1485 - 1490, XP002211263 [DX] 6-8,53-55 * abstract * * page 1487, column LEFT, line 9 - line 18 * * page 1488, column LEFT, line 13 - column RIGHT, line 18 * * page 1489, column RIGHT, line 25 - page 1490, column LEFT, line 2 * * figures 3,4 * DOI: http://dx.doi.org/10.1073/pnas.022662599 | [X] - HUBBARD G B ET AL, "Spontaneous pancreatic islet amyloidosis in 40 baboons.", JOURNAL OF MEDICAL PRIMATOLOGY APR 2002, (200204), vol. 31, no. 2, ISSN 0047-2565, pages 84 - 90, XP002498011 [X] 7,8 * abstract * DOI: http://dx.doi.org/10.1034/j.1600-0684.2002.01020.x | Examination | - YUTANI K ET AL, "The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus.", BIOCHEMISTRY 14 MAR 2000 LNKD- PUBMED:10704229, (20000314), vol. 39, no. 10, doi:10.1021/bi991406v, ISSN 0006-2960, pages 2769 - 2777, XP001128143 DOI: http://dx.doi.org/10.1021/bi991406v | - AKIYAMA H ET AL, "Inflammation and Alzheimer's disease.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200005), Database accession no. NLM10858586 | - NEUROBIOLOGY OF AGING 2000 MAY-JUN LNKD- PUBMED:10858586, (200005), vol. 21, no. 3, ISSN 0197-4580, pages 383 - 421 | by applicant | - BUCCIANTINI M; GIANNONI E; CHITI F ET AL., "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases", NATURE, (2002), vol. 416, doi:doi:10.1038/416507a, pages 507 - 511, XP001174110 DOI: http://dx.doi.org/10.1038/416507a | - ROCHET JC; LANSBURY PT, JR., "Amyloid fibrillogenesis: themes and variations", CURR OPIN STRUCT BIOL., (2000), vol. 10, pages 60 - 68 | - CARMELIET P; BOUCHE A; DE CLERCQ C ET AL., "Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in mice", ANN N Y ACAD SCI., (1995), vol. 748, pages 367 - 381 | - CARMELIET P; COLLEN D., "Genetic analysis of the plasminogen and coagulation system in mice", HAEMOSTASIS, (1996), vol. 26, no. 4, pages 132 - 153 | - COLLEN D; LIJNEN HR, "Molecular basis of fibrinolysis, as relevant for thrombolytic therapy", THROMB HAEMOST., (1995), vol. 74, pages 167 - 171 | - LIJNEN HR; COLLEN D., "Mechanisms of physiological fibrinolysis", BAILLIERES CLIN HAEMATOL, (1995), vol. 8, pages 277 - 290 | - BOSMA PJ; RIJKEN DC; NIEUWENHUIZEN W., "Binding of tissue-type plasminogen activator to fibrinogen fragments", EUR J BIOCHEM., (1988), vol. 17, no. 2, pages 399 - 404 | - GRAILHE P; NIEUWENHUIZEN W; ANGLES-CANO E., "Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen", EUR J BIOCHEM., (1994), vol. 219, pages 961 - 967 | - NIEUWENHUIZEN W., "Fibrin-mediated plasminogen activation", ANN N Y ACAD SCI., (2001), vol. 936, doi:doi:10.1111/j.1749-6632.2001.tb03512.x, pages 237 - 246, XP055023314 DOI: http://dx.doi.org/10.1111/j.1749-6632.2001.tb03512.x | - YAKOVLEV S ET AL., "Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites", BIOCHEMISTRY, (2000), vol. 39, pages 15730 - 15741 | - BAKKER AH; WEENING-VERHOEFF EJ; VERHEIJEN JH., "The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot", J BIOL CHEM., (1995), vol. 270, doi:doi:10.1074/jbc.270.21.12355, pages 12355 - 12360, XP002319385 DOI: http://dx.doi.org/10.1074/jbc.270.21.12355 | - DE MUNK GA ET AL., "Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments", BIOCHEMISTRY, (1989), vol. 28, doi:doi:10.1021/bi00444a026, pages 7318 - 7325, XP002928602 DOI: http://dx.doi.org/10.1021/bi00444a026 | - FLEURY V ET AL., "Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface", EUR J BIOCHEM., (1993), vol. 216, pages 549 - 556 | - HADDELAND U ET AL., "Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation", THROMB HAEMOST., (1996), vol. 75, pages 326 - 331 | - HASAN AA; CHANG WS; BUDZYNSKI AZ., "Binding of fibrin fragments to one-chain and two- chain tissue-type plasminogen activator", BLOOD, (1992), vol. 79, pages 2313 - 2321 | - NIEUWENHUIZEN W ET AL., "Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator", BIOCHIM BIOPHYS ACTA, (1983), vol. 748, doi:doi:10.1016/0167-4838(83)90030-4, pages 86 - 92, XP025210540 DOI: http://dx.doi.org/10.1016/0167-4838(83)90030-4 | - NIEUWENHUIZEN W ET AL., "Studies on the localization and accessibility of sites in fibrin which are involved in the acceleration of the activation of plasminogen by tissue-type plasminogen activator", ADV EXP MED BIOL., (1990), vol. 281, pages 83 - 91 | - NIEUWENHUIZEN W., "Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation", THROMB RES., (1994), vol. 75, doi:doi:10.1016/0049-3848(94)90248-8, pages 343 - 347, XP022881390 DOI: http://dx.doi.org/10.1016/0049-3848(94)90248-8 | - SCHIELEN WJ ET AL., "The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen", BLOOD COAGUL FIBRINOLYSIS, (1991), vol. 2, pages 465 - 470 | - TSURUPA G; MEDVED L., "Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains", BIOCHEMISTRY, (2001), vol. 40, pages 801 - 808 | - YONEKAWA O; VOSKJIEN M; NIEUWENHUIZEN W., "Localization in the fibrinogen gamma- chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen", BIOCHEM J., (1992), vol. 283, no. 1, pages 187 - 191 | - BOBBINK IW ET AL., "Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation", BIOCHEM BIOPHYS RES COMMUN, (1997), vol. 240, pages 595 - 601 | - HU GF; RIORDAN JF., "Angiogenin enhances actin acceleration of plasminogen activation", BIOCHEM BIOPHYS RES COMMUN, (1993), vol. 197, doi:doi:10.1006/bbrc.1993.2533, pages 682 - 687, XP024766756 DOI: http://dx.doi.org/10.1006/bbrc.1993.2533 | - KINGSTON IB; CASTRO MJ; ANDERSON S., "In vitro stimulation of tissue-type plasminogen activator byAlzheimer amyloid beta-peptide analogues", NAT MED., (1995), vol. 1, pages 138 - 142 | - LIND SE; SMITH CJ, "Actin accelerates plasmin generation by tissue plasminogen activator", J BIOL CHEM., (1991), vol. 266, pages 17673 - 17678 | - MACHOVICH R; OWEN WG., "Denatured proteins as cofactors for plasminogen activation", ARCH BIOCHEM BIOPHYS, (1997), vol. 344, doi:doi:10.1006/abbi.1997.0221, pages 343 - 349, XP002175284 DOI: http://dx.doi.org/10.1006/abbi.1997.0221 | - MACHOVICH R ET AL., "Myosin as cofactor and substrate in fibrinolysis", FEBS LETT., (1997), vol. 407, doi:doi:10.1016/S0014-5793(97)00303-7, pages 93 - 96, XP002175285 DOI: http://dx.doi.org/10.1016/S0014-5793(97)00303-7 | - MACHOVICH R ET AL., "Facilitation of plasminogen activation by denatured prothrombin", THROMB RES., (1999), vol. 94, pages 389 - 394 | - PARKKINEN J; HACKER J; KORHONEN TK., "Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis", THROMB HAEMOST., (1991), vol. 65, pages 483 - 486 | - PARKKINEN J; RAUVALA H., "Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin", J BIOL CHEM., (1991), vol. 266, pages 16730 - 16735 | - PRYZDIAL EL; BAJZAR L; NESHEIM ME., "Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation", J BIOL CHEM., (1995), vol. 270, doi:doi:10.1074/jbc.270.30.17871, pages 17871 - 17877, XP002290381 DOI: http://dx.doi.org/10.1074/jbc.270.30.17871 | - RADCLIFFE R; HEINZE T., "Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator", ARCH BIOCHEM BIOPHYS., (1981), vol. 211, doi:doi:10.1016/0003-9861(81)90512-9, pages 750 - 761, XP024757260 DOI: http://dx.doi.org/10.1016/0003-9861(81)90512-9 | - SHENG S ET AL., "Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin", PROC NATL ACAD SCI USA., (1998), vol. 95, pages 499 - 504 | - SILVERSTEIN RL ET AL., "Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator", J CLIN INVEST., (1984), vol. 74, pages 1625 - 1633 | - STACK S; GONZALEZ-GRONOW M; PIZZO SV., "Regulation of plasminogen activation by components of the extracellular matrix", BIOCHEMISTRY, (1990), vol. 29, pages 4966 - 4970 | - WADA H; KUMEDA Y; OGASAWARA Z ET AL., "Stimulation of tissue type plasminogen activator by leukaemic cell homogenates", BLOOD COAGUL FIBRINOLYSIS, (1993), vol. 4, pages 591 - 597 | - CARRELL RW; GOOPTU B., "Conformational changes and disease--serpins, prions and Alzheimer's", CURR OPIN STRUCT BIOL., (1998), vol. 8, doi:doi:10.1016/S0959-440X(98)80101-2, pages 799 - 809, XP009012236 DOI: http://dx.doi.org/10.1016/S0959-440X(98)80101-2 | - KRIEGER M; STERN DM., "Series introduction: multiligand receptors and human disease", J CLIN INVEST., (2001), vol. 108, pages 645 - 647 | - SCHMIDT AM ET AL., "Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis", CIRC RES., (1999), vol. 84, pages 489 - 497 | - SCHMIDT AM ET AL., "The biology of the receptor for advanced glycation end products and its ligands", BIOCHIM BIOPHYS ACTA, (2000), vol. 1498, doi:doi:10.1016/S0167-4889(00)00087-2, pages 99 - 111, XP004278211 DOI: http://dx.doi.org/10.1016/S0167-4889(00)00087-2 | - SCHMIDT AM ET AL., "RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation", SEMIN THROMB HEMOST., (2000), vol. 26, pages 485 - 493 | - SCHMIDT AM ET AL., "The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses", J CLIN INVEST., (2001), vol. 108, doi:doi:10.1172/JCI200114002, pages 949 - 955, XP002994307 DOI: http://dx.doi.org/10.1172/JCI200114002 | - WELDON DT; MAGGIO JE; MANTYH PW., "New insights into the neuropathology and cell biology of Alzheimer's disease", GERIATRICS, (1997), vol. 52, no. 2, pages S13 - S16 | - YAN SD ET AL., "Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide", BIOCHIM BIOPHYS ACTA, (2000), vol. 1502, doi:doi:10.1016/S0925-4439(00)00041-7, pages 145 - 157, XP004276982 DOI: http://dx.doi.org/10.1016/S0925-4439(00)00041-7 | - BALBACH JJ; ISHII Y; ANTZUTKIN ON ET AL., "Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR", BIOCHEMISTRY, (2000), vol. 39, pages 13748 - 13759 | - BOBBINK IW ET AL., "Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin", DIABETES, (1997), vol. 46, pages 87 - 93 | - BOEHM T ET AL., "Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance", NATURE, (1997), vol. 390, doi:doi:10.1038/37126, pages 404 - 407, XP000857413 DOI: http://dx.doi.org/10.1038/37126 | - ANDRADE MA ET AL., "Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network", PROTEIN ENG., (1993), vol. 6, pages 383 - 390 | - KRANENBURG O; BOUMA B; KROON-BATENBURG LM ET AL., "Tissue-type plasminogen activator is a multiligand cross-beta structure receptor", CURR BIOL., (2002), vol. 12, pages 1833 - 1839 | - VAN ZONNEVELD AJ; VEERMAN H; PANNEKOEK H., "On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.", J BIOL CHEM., (1986), vol. 261, pages 14214 - 14218, XP001317647 | - LEVINE H, III, "Quantification of beta-sheet amyloid fibril structures with thioflavin T", METHODS ENZYMOL., (1999), vol. 309, doi:doi:10.1016/S0076-6879(99)09020-5, pages 274 - 284, XP002930179 DOI: http://dx.doi.org/10.1016/S0076-6879(99)09020-5 | - KRANENBURG O ET AL., "Inhibition of cychn- dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells", J CELL BIOL., (1995), vol. 131, pages 227 - 234 | - JOHANNESSEN M; DINESS V; PINGEL K ET AL., "Fibrin affinity and clearance of t-PA deletion and substitution analogues", THROMB HAEMOST., (1990), vol. 6, no. 3, pages 54 - 59 | - GEBBINK MF ET AL., "Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact", J CELL BIOL., (1995), vol. 131, pages 251 - 260 | - STEWART RJ; FREDENBURGH JC; WEITZ JI, "Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E", J BIOL CHEM., (1998), vol. 273, pages 18292 - 18299 | - TUCKER HM; KIHIKO M; CALDWELL JN ET AL., "The plasmin system is induced by and degrades amyloid-beta aggregates", J NEUROSCI., (2000), vol. 20, pages 3937 - 3946, XP002217265 | - TUCKER HM ET AL., "Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition", J NEUROCHEM., (2000), vol. 75, pages 2172 - 2177 | - REDLITZ A ET AL., "Plasma carboxypeptidases as regulators of the plasminogen system", J CLIN INVEST., (1995), vol. 96, doi:doi:10.1172/JCI118315, pages 2534 - 2538, XP001033705 DOI: http://dx.doi.org/10.1172/JCI118315 | - HAYDEN MR; TYAGI SC., ""A" is for amylin and amyloid in type 2 diabetes mellitus", JOP, (2001), vol. 2, pages 124 - 139 | - MORIARTY DF; RALEIGH DP., "Effects of sequential proline substitutions on amyloid formation by human amylin20-29", BIOCHEMISTRY, (1999), vol. 38, doi:doi:10.1021/bi981658g, pages 1811 - 1818, XP002249402 DOI: http://dx.doi.org/10.1021/bi981658g | - SAISHOJI T; HIGASHI T; IKEDA K ET AL., "Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells", BIOCHEM BIOPHYS RES COMMUN., (1995), vol. 217, pages 278 - 285 | - NGUYEN JT; INOUYE H; BALDWIN MA ET AL., "X-ray diffraction of scrapie prion rods and PrP peptides", J MOL BIOL., (1995), vol. 252, pages 412 - 422 | - MOTOMIYA Y ET AL., "N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis", KIDNEY INT., (1998), vol. 54, pages 1357 - 1366 | - SADY C; JIANG CL; CHELLAN P ET AL., "Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins", BIOCHIM BIOPHYS ACTA, (2000), vol. 1481, doi:doi:10.1016/S0167-4838(00)00133-3, pages 255 - 264, XP004279007 DOI: http://dx.doi.org/10.1016/S0167-4838(00)00133-3 | - SHIBAYAMA Y ET AL., "Zinc- dependent activation of the plasma ki:nin.-forming cascade by aggregated beta amyloid protein", CLIN IMMUNOL., (1999), vol. 90, pages 89 - 99 | - BENNETT WF; PAONI NF; KEYT BA ET AL., "High resolution analysis of functional determinants on human tissue-type plasminogen activator", J BIOL CHEM., (1991), vol. 266, pages 5191 - 5201, XP002053063 | - HORREVOETS AJ ET AL., "The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis", J BIOL CHEM., (1994), vol. 269, pages 12639 - 12644, XP002235245 | - MATSUKA YV ET AL., "The NH2-terminal fibrin-binding site of fibronectin is formed by interacting fourth and fifth finger domains. Studies with recombinant finger fragments expressed in Escherichia coli", J BIOL CHEM., (1994), vol. 269, pages 9539 - 9546, XP000887290 | - BECKMANN R ET AL., "Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator", J BIOL CHEM., (1991), vol. 266, pages 2227 - 2232 | - O'NUALLAIN B; WETZEL R., "Conformational Abs recognizing a generic amyloid fibril epitope", PROC NATL ACAD SCI U S A., (2002), vol. 99, doi:doi:10.1073/pnas.022662599, pages 1485 - 1490, XP002211263 DOI: http://dx.doi.org/10.1073/pnas.022662599 | - KAYED R; HEAD E; THOMPSON JL ET AL., "Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis", SCIENCE, (2003), vol. 300, pages 486 - 489 | - CUTLER P; BROWN F; CAMILLERI P ET AL., "The recognition of haemoglobin by antibodies raised for the immunoassay of beta-amyloid", FEBS LETT., (1997), vol. 412, pages 341 - 345 | - STERN RA; TROJANOWSKI JQ; LEE VM., "Antibodies to the beta-amyloid peptide cross-react with conformational epitopes in human fibrinogen subunits from peripheral blood", FEBS LETT., (1990), vol. 264, doi:doi:10.1016/0014-5793(90)80760-G, pages 43 - 47, XP001153493 DOI: http://dx.doi.org/10.1016/0014-5793(90)80760-G | - DOWNING AK; DRISCOLL PC; HARVEY TS ET AL., "Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance", J MOL BIOL., (1992), vol. 225, doi:doi:10.1016/0022-2836(92)90403-7, pages 821 - 833, XP024022070 DOI: http://dx.doi.org/10.1016/0022-2836(92)90403-7 | - SMITH BO ET AL., "The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor-like pair of modules of tissue-type plasminogen activator", STRUCTURE, (1995), vol. 3, doi:doi:10.1016/S0969-2126(01)00217-9, pages 823 - 833, XP004587895 DOI: http://dx.doi.org/10.1016/S0969-2126(01)00217-9 | - WILLIAMS MJ ET AL., "Solution structure of a pair of fibronectin type 1 modules with fibrin binding activity", J MOL BIOL., (1994), vol. 235, doi:doi:10.1006/jmbi.1994.1083, pages 1302 - 1311, XP024008617 DOI: http://dx.doi.org/10.1006/jmbi.1994.1083 |